Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis

OBJECTIVES: We examined whether eldecalcitol (ELD) provided additive bone mineral density (BMD) and bone turnover marker gains in patients undergoing long-term bisphosphonate (BP) usage, especially in osteoporotic individuals exhibiting a poor response to BPs. METHODS: Forty-two post-menopausal pati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Osteoporos Sarcopenia
Autors principals: Kamimura, Mikio, Ikegami, Shota, Mukaiyama, Keijiro, Koiwai, Hidefumi, Nakamura, Yukio, Taguchi, Akira, Kato, Hiroyuki
Format: Artigo
Idioma:Inglês
Publicat: Korean Society of Osteoporosis 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6630044/
https://ncbi.nlm.nih.gov/pubmed/31346557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.afos.2019.06.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars